Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01616212 · ClinicalTrials.gov registry record · Phase 1

Early Intervention for Minors in Possession of Alcohol/Drugs: A Feasibility Study

A Phase 1 study of Substance Use Disorder and Delinquency, sponsored by Oregon Research Institute.

Completed
Registry status
Phase 1
Development phase
239
Enrollment target
1
Study location

NCT01616212: Completed Phase 1 study of Substance Use Disorder and Delinquency, sponsored by Oregon Research Institute.

NCT01616212 is a Phase 1 study of Substance Use Disorder and Delinquency that has completed, run by Oregon Research Institute. The registered enrollment target is 239 participants, below the 809-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01616212, a Phase 1 study of Substance Use Disorder and Delinquency, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
Phase 1
Development phase
239 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate two brief, sustainable interventions for a sample of 280 adolescents charged with an initial drug-related offense: Motivational Enhancement Therapy (MET) intervention for youth and the Parenting Wisely (PW) intervention for parents. Families are assessed for adolescent substance use, HIV-risk, recidivist substance-related offenses, treatment entry, and other areas of individual and family functioning. It is expected that the combined MET+PW interventions will be more effective than a treatment-as-usual intervention (drug education group) for adolescents with parents not participating in PW.

Primary Outcome

The questionnaire used is called the Time Line Follow Back.

Interventions

  • OTHER Motivational Enhancement Therapy /Adol and PW for parents
  • OTHER Motivational Enhancement Therapy for adolescents
  • OTHER Drug Education for adolescents, Parenting Wisely for parents
  • OTHER Drug Education for adolescents

Study Locations (1)

Oregon

  • Oregon Research Institute - Portland

Trial Details

FieldValue
Enrollment Target 239 participants
Start Date 2011-07
Est. Completion 2014-09
Phase Phase 1
Oregon Research Institute

62 total trials

What the finished NCT01616212 record still lists

NCT01616212 is an interventional study that assigns participants to a tested intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap, below the 809-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (70% lower).

The record links to 2 conditions, with Substance Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Motivational Enhancement Therapy /Adol and PW for parents is the first listed.

NCT01616212 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT01616212 about?

NCT01616212 is a clinical study titled "Early Intervention for Minors in Possession of Alcohol/Drugs: A Feasibility Study". The purpose of this study is to evaluate two brief, sustainable interventions for a sample of 280 adolescents charged with an initial drug-related offense: Motivational Enhancement Therapy (MET) intervention for youth and the Parenting Wisely (PW) intervention for parents. Families are assessed for ...

What is the current status of trial NCT01616212?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 239 participants. The study started on 2011-07. Estimated completion is 2014-09.

What conditions does trial NCT01616212 study?

This clinical trial studies the following conditions: Substance Use Disorder, Delinquency.

What interventions are being tested in trial NCT01616212?

The interventions under investigation include: Motivational Enhancement Therapy /Adol and PW for parents (OTHER), Motivational Enhancement Therapy for adolescents (OTHER), Drug Education for adolescents, Parenting Wisely for parents (OTHER), Drug Education for adolescents (OTHER).

Who is sponsoring clinical trial NCT01616212?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01616212 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01616212's enrollment target sits among peer trials

239 5th of 18 higher than 14 of 18 other Substance Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01616212, the US trial registry maintained by the National Library of Medicine. NCT01616212 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.